1st Circ. Cites Levine To Free Forest In Lexapro Label Suit
The First Circuit on Friday tossed a proposed class action claiming that the labels on Forest Pharmaceuticals Inc.'s antidepressant Lexapro overstated its efficacy, finding that federal rules preempt state claims that...To view the full article, register now.
Already a subscriber? Click here to view full article